DEFINIUM THERAPEUTICS INC
DFTX · NASDAQ
Updated at 2026-10-14 10:03:30
- Today's High
- $34.95
- Today’s Low
- $34.03
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $36.27
- Previous Close
- $35.20
- Volume
- 1.9M
- Market Cap
- $4.72B
- P/E Ratio
- --
- EPS
- $-3.42
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- ONE WORLD TRADE CENTER, NEW YORK, NY, UNITED STATES, 10007
- Country
- US
- Listing Date
- 2015-05-04
- Fiscal Year End
- December
- Shares Outstanding
- 124.63M
- CIK
- 0001813814
- Website
- definiumtx.com
Definium Therapeutics, Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$75.07M
2026-03-31
$59.22M
2025-12-31
$47.57M
2025-09-30
$45.66M
Net Income
2026-06-30
-$158.98M
2026-03-31
-$77.09M
2025-12-31
-$50.43M
2025-09-30
-$67.26M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.44
2026-03-31
$-0.71
2025-12-31
$-0.45
2025-09-30
$-0.78
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$157.75M
2026-03-31
-$75.22M
2025-12-31
-$40.74M
2025-09-30
-$65.98M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $75.07M | $59.22M | $47.57M | $45.66M |
| Net Income | -$158.98M | -$77.09M | -$50.43M | -$67.26M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.44 | $-0.71 | $-0.45 | $-0.78 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$157.75M | -$75.22M | -$40.74M | -$65.98M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.